AAAAAA

   
Results: 1-13 |
Results: 13
METHYLPHENIDATE THERAPY IMPROVES COGNITION, MOOD, AND FUNCTION OF BRAIN-TUMOR PATIENTS
Authors: MEYERS CA WEITZNER MA VALENTINE AD LEVIN VA
Citation: Ca. Meyers et al., METHYLPHENIDATE THERAPY IMPROVES COGNITION, MOOD, AND FUNCTION OF BRAIN-TUMOR PATIENTS, Journal of clinical oncology, 16(7), 1998, pp. 2522-2527
MOOD AND COGNITIVE SIDE-EFFECTS OF INTERFERON-ALPHA THERAPY
Authors: VALENTINE AD MEYERS CA KLING MA RICHELSON E HAUSER P
Citation: Ad. Valentine et al., MOOD AND COGNITIVE SIDE-EFFECTS OF INTERFERON-ALPHA THERAPY, Seminars in oncology, 25(1), 1998, pp. 39-47
MANIC EPISODES IN 2 PATIENTS TREATED WITH INTERFERON-ALPHA
Authors: STRITE D VALENTINE AD MEYERS CA
Citation: D. Strite et al., MANIC EPISODES IN 2 PATIENTS TREATED WITH INTERFERON-ALPHA, The Journal of neuropsychiatry and clinical neurosciences, 9(2), 1997, pp. 273-276
RETROSPECTIVE STUDY OF THE PSYCHIATRIC MANAGEMENT AND OUTCOME OF DELIRIUM IN THE CANCER-PATIENT
Authors: OLOFSSON SM WEITZNER MA VALENTINE AD BAILE WF MEYERS CA
Citation: Sm. Olofsson et al., RETROSPECTIVE STUDY OF THE PSYCHIATRIC MANAGEMENT AND OUTCOME OF DELIRIUM IN THE CANCER-PATIENT, Supportive care in cancer, 4(5), 1996, pp. 351-357
INTERFERON-ALFA - REPLY
Authors: VALENTINE AD PAVOL MA MEYERS CA
Citation: Ad. Valentine et al., INTERFERON-ALFA - REPLY, Neurology, 47(1), 1996, pp. 309-309
NEUROLOGICAL AND PSYCHIATRIC ADVERSE-EFFECTS OF IMMUNOLOGICAL THERAPY
Authors: MEYERS CA VALENTINE AD
Citation: Ca. Meyers et Ad. Valentine, NEUROLOGICAL AND PSYCHIATRIC ADVERSE-EFFECTS OF IMMUNOLOGICAL THERAPY, CNS DRUGS, 3(1), 1995, pp. 56-68
STUDIES WITH [C-11] ALPRAZOLAM - AN AGONIST FOR THE BENZODIAZEPINE RECEPTOR
Authors: DOBBS FR BANKS W FLEISHAKER JC VALENTINE AD KINSEY BM FRANCESCHINI MP DIGENIS GA TEWSON TJ
Citation: Fr. Dobbs et al., STUDIES WITH [C-11] ALPRAZOLAM - AN AGONIST FOR THE BENZODIAZEPINE RECEPTOR, Nuclear medicine and biology, 22(4), 1995, pp. 459-466
METHYLPHENIDATE IN THE TREATMENT OF NEUROBEHAVIORAL SLOWING ASSOCIATED WITH CANCER AND CANCER-TREATMENT
Authors: WEITZNER MA MEYERS CA VALENTINE AD
Citation: Ma. Weitzner et al., METHYLPHENIDATE IN THE TREATMENT OF NEUROBEHAVIORAL SLOWING ASSOCIATED WITH CANCER AND CANCER-TREATMENT, The Journal of neuropsychiatry and clinical neurosciences, 7(3), 1995, pp. 347-350
TREATMENT OF NEUROTOXIC SIDE-EFFECTS OF INTERFERON-ALPHA WITH NALTREXONE
Authors: VALENTINE AD MEYERS CA TALPAZ M
Citation: Ad. Valentine et al., TREATMENT OF NEUROTOXIC SIDE-EFFECTS OF INTERFERON-ALPHA WITH NALTREXONE, Cancer investigation, 13(6), 1995, pp. 561-566
SUCCESSFUL TREATMENT OF INTERFERON-ALPHA-INDUCED MOOD DISORDER WITH NORTRIPTYLINE
Authors: VALENTINE AD MEYERS CA
Citation: Ad. Valentine et Ca. Meyers, SUCCESSFUL TREATMENT OF INTERFERON-ALPHA-INDUCED MOOD DISORDER WITH NORTRIPTYLINE, Psychosomatics, 36(4), 1995, pp. 418-419
PATTERN OF NEUROBEHAVIORAL DEFICITS ASSOCIATED WITH INTERFERON-ALFA THERAPY FOR LEUKEMIA
Authors: PAVOL MA MEYERS CA REXER JL VALENTINE AD MATTIS PJ TALPAZ M
Citation: Ma. Pavol et al., PATTERN OF NEUROBEHAVIORAL DEFICITS ASSOCIATED WITH INTERFERON-ALFA THERAPY FOR LEUKEMIA, Neurology, 45(5), 1995, pp. 947-950
THE ABILITY OF DENTAL TEAM MEMBERS TO DISCRIMINATE BETWEEN INDIVIDUALCERAMIC SHADE TABS OF ONE SHADE DETERMINATION SYSTEM
Authors: GEARY JL VALENTINE AD KINIRONS MJ
Citation: Jl. Geary et al., THE ABILITY OF DENTAL TEAM MEMBERS TO DISCRIMINATE BETWEEN INDIVIDUALCERAMIC SHADE TABS OF ONE SHADE DETERMINATION SYSTEM, Journal of dental research, 74(3), 1995, pp. 950-950
REVERSIBLE NEUROTOXICITY OF INTERLEUKIN-2 AND TUMOR-NECROSIS-FACTOR -CORRELATION OF SPECT WITH NEUROPSYCHOLOGICAL TESTING
Authors: MEYERS CA VALENTINE AD WONG FCL LEEDS NE
Citation: Ca. Meyers et al., REVERSIBLE NEUROTOXICITY OF INTERLEUKIN-2 AND TUMOR-NECROSIS-FACTOR -CORRELATION OF SPECT WITH NEUROPSYCHOLOGICAL TESTING, The Journal of neuropsychiatry and clinical neurosciences, 6(3), 1994, pp. 285-288
Risultati: 1-13 |